SCNNG_HUMAN - dbPTM
SCNNG_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID SCNNG_HUMAN
UniProt AC P51170
Protein Name Amiloride-sensitive sodium channel subunit gamma
Gene Name SCNN1G
Organism Homo sapiens (Human).
Sequence Length 649
Subcellular Localization Apical cell membrane
Multi-pass membrane protein . Apical membrane of epithelial cells.
Protein Description Sodium permeable non-voltage-sensitive ion channel inhibited by the diuretic amiloride. Mediates the electrodiffusion of the luminal sodium (and water, which follows osmotically) through the apical membrane of epithelial cells. Plays an essential role in electrolyte and blood pressure homeostasis, but also in airway surface liquid homeostasis, which is important for proper clearance of mucus. Controls the reabsorption of sodium in kidney, colon, lung and sweat glands. Also plays a role in taste perception..
Protein Sequence MAPGEKIKAKIKKNLPVTGPQAPTIKELMRWYCLNTNTHGCRRIVVSRGRLRRLLWIGFTLTAVALILWQCALLVFSFYTVSVSIKVHFRKLDFPAVTICNINPYKYSTVRHLLADLEQETREALKSLYGFPESRKRREAESWNSVSEGKQPRFSHRIPLLIFDQDEKGKARDFFTGRKRKVGGSIIHKASNVMHIESKQVVGFQLCSNDTSDCATYTFSSGINAIQEWYKLHYMNIMAQVPLEKKINMSYSAEELLVTCFFDGVSCDARNFTLFHHPMHGNCYTFNNRENETILSTSMGGSEYGLQVILYINEEEYNPFLVSSTGAKVIIHRQDEYPFVEDVGTEIETAMVTSIGMHLTESFKLSEPYSQCTEDGSDVPIRNIYNAAYSLQICLHSCFQTKMVEKCGCAQYSQPLPPAANYCNYQQHPNWMYCYYQLHRAFVQEELGCQSVCKEACSFKEWTLTTSLAQWPSVVSEKWLLPVLTWDQGRQVNKKLNKTDLAKLLIFYKDLNQRSIMESPANSIEMLLSNFGGQLGLWMSCSVVCVIEIIEVFFIDFFSIIARRQWQKAKEWWAWKQAPPCPEAPRSPQGQDNPALDIDDDLPTFNSALHLPPALGTQVPGTPPPKYNTLRLERAFSNQLTDTQMLDEL
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
6Ubiquitination--MAPGEKIKAKIKK
--CCCHHHHHHHHHH
56.26-
8UbiquitinationMAPGEKIKAKIKKNL
CCCHHHHHHHHHHCC
55.489351815
10UbiquitinationPGEKIKAKIKKNLPV
CHHHHHHHHHHCCCC
50.489351815
12UbiquitinationEKIKAKIKKNLPVTG
HHHHHHHHHCCCCCC
34.609351815
13UbiquitinationKIKAKIKKNLPVTGP
HHHHHHHHCCCCCCC
68.169351815
26UbiquitinationGPQAPTIKELMRWYC
CCCCCHHHHHHHHHH
47.479351815
47PhosphorylationGCRRIVVSRGRLRRL
CCEEEEEECHHHHHH
20.3724719451
98PhosphorylationKLDFPAVTICNINPY
CCCCCEEEEECCCCC
23.17-
108PhosphorylationNINPYKYSTVRHLLA
CCCCCCHHHHHHHHH
19.10-
109PhosphorylationINPYKYSTVRHLLAD
CCCCCHHHHHHHHHH
20.61-
142PhosphorylationRKRREAESWNSVSEG
HHHHHHHHHCCCCCC
38.3129978859
145PhosphorylationREAESWNSVSEGKQP
HHHHHHCCCCCCCCC
22.2928509920
147PhosphorylationAESWNSVSEGKQPRF
HHHHCCCCCCCCCCC
40.2128509920
176PhosphorylationGKARDFFTGRKRKVG
CCCCCCCCCCCCEEC
35.7524719451
185PhosphorylationRKRKVGGSIIHKASN
CCCEECCCEEEECCC
16.6722210691
209N-linked_GlycosylationVGFQLCSNDTSDCAT
EEEEEECCCCCCCEE
56.43UniProtKB CARBOHYD
495AcetylationQGRQVNKKLNKTDLA
HHHHHHHHCCCCHHH
52.6812649891
497N-linked_GlycosylationRQVNKKLNKTDLAKL
HHHHHHCCCCHHHHH
54.80UniProtKB CARBOHYD
498AcetylationQVNKKLNKTDLAKLL
HHHHHCCCCHHHHHH
54.5812649903
503AcetylationLNKTDLAKLLIFYKD
CCCCHHHHHHHHHHC
51.6412649915
622PhosphorylationLGTQVPGTPPPKYNT
CCCCCCCCCCCCCCC
26.9311805112
629PhosphorylationTPPPKYNTLRLERAF
CCCCCCCCHHHHHHH
15.34-
637PhosphorylationLRLERAFSNQLTDTQ
HHHHHHHHCCCCCCH
23.7628857561
641PhosphorylationRAFSNQLTDTQMLDE
HHHHCCCCCCHHHHC
27.51-

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
-KUbiquitinationE3 ubiquitin ligaseNEDD4P46934
PMID:17013377
-KUbiquitinationE3 ubiquitin ligaseNEDD4LQ96PU5
PMID:14556380

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of SCNNG_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of SCNNG_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
NEDD4_HUMANNEDD4physical
10642508
NEDD4_HUMANNEDD4physical
11244092
NED4L_HUMANNEDD4Lphysical
11244092
EPN1_HUMANEPN1physical
16574660
NED4L_HUMANNEDD4Lphysical
16416336
UBP2_HUMANUSP2physical
18701608
SERP1_HUMANSERP1physical
22526458

Drug and Disease Associations
Kegg Disease
H00242 Liddle syndrome
H00243 Hyperkalemic distal renal tubular acidosis (RTA type 4), including: Pseudohypoaldosteronism type I
H00892 Bronchiectasis with or without elevated sweat chloride
OMIM Disease
177200Liddle syndrome (LIDDS)
613071Bronchiectasis with or without elevated sweat chloride 3 (BESC3)
Kegg Drug
D00386 Triamterene (JP16/USP/INN); Dyrenium (TN)
D00649 Amiloride hydrochloride (USP); Midamor (TN)
D07447 Amiloride (INN); Amiclaran (TN)
DrugBank
DB00594Amiloride
DB00384Triamterene
Regulatory Network of SCNNG_HUMAN

loading...

Related Literatures of Post-Translational Modification

TOP